Gaudium IVF and Women Health Limited (NSE:GAUDIUMIVF)

Market Cap	5.77B
Revenue (ttm)	1.01B +128.1%
Net Income	226.74M +67.6%
EPS	3.70 +68.0%
Shares Out	72.79M
PE Ratio	21.45
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	760,756
Average Volume	818,419
Open	77.99
Previous Close	76.51
Day's Range	75.05 - 80.24
52-Week Range	69.18 - 99.75
Beta	n/a
RSI	49.23
Earnings Date	Mar 18, 2026

About NSE:GAUDIUMIVF

Gaudium IVF and Women Health Limited provides in vitro fertilization (IVF) treatment in India. The company offers fertility and reproductive health services, including intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), and ovulation induction; polycystic ovarian syndrome (PCOS)/ polycystic ovarian disease (PCOD); endometriosis treatment; ovulation induction; and laser assisted embryo implantation services. It also provides male infertility treatment services; infertility surgeries; egg freezing; surrogacy; and laparoscopi...

• Industry: Specialty Outpatient Facilities, Not Elsewhere Classified
• Founded: 2009
• Employees: 117
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: GAUDIUMIVF

Financial Performance

In fiscal year 2025, NSE:GAUDIUMIVF's revenue was 707.24 million, an increase of 47.68% compared to the previous year's 478.90 million. Earnings were 191.27 million, an increase of 85.40%.